Table 2 Information on the patients and implants at the 2-year follow-up after implant placement
Variable | Insulin group | Metformin group | GLP-1 drug group | P |
|---|---|---|---|---|
Total patients (n) | 30 | 24 | 17 | Â |
Age (y) | 55.9 ± 8.9 | 55.0 ± 8.0 | 55.5 ± 7.7 | 0.926 |
HbA1c (%) | 7.1 ± 0.5 | 7.4 ± 0.3 | 7.3 ± 0.5 | 0.188 |
Sex | ||||
Male/female | 20/10 | 21/3 | 12/5 | 0.197 |
Total implants (n) | 53 | 44 | 32 | Â |
Length (mm) | 10.6 ± 1.7 | 10.8 ± 1.4 | 11.0 ± 1.9 | 0.568 |
Arch | ||||
Maxillary/mandibular | 33/20 | 23/21 | 20/12 | 0.544 |
Location | ||||
Anterior/posterior | 10/43 | 12/32 | 6/26 | 0.544 |
Position of fixture | ||||
Submerged /non-submerged | 33/20 | 21/23 | 22/10 | 0.150 |
Major surface treatment | ||||
SLA/Anodic oxidation | 23/30 | 28/16 | 14/18 | 0.096 |
Restoration type | ||||
Single/multiple ceramic restoration | 25/28 | 10/34 | 13/19 | 0.042* |